Insider trade

Officer received an award of 22K ABT shares

Traded Feb 24, 2026 · Filed Feb 27, 2026

Abbott LaboratoriesABT

22K
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 24, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 27, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001620564-26-000002
Filed / recorded

Feb 27, 2026, 12:02 AM UTC

Added to OQRO

Oct 2, 2026, 12:26 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

ABBOTT LABORATORIES

Issuer CIK

1800

Ticker

ABT

Reporting person

Daniel Gesua Sive Salvadori

Relationship

Officer

Officer title

EVP AND GROUP PRESIDENT

Security

Common shares without par value

Table

Non-derivative (Table I)

Transaction date

Feb 24, 2026

Transaction code

A

Shares / units

21,644

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

153,877

Ownership form

Direct

Amendment

No

Footnotes from the filing

These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.